Vasonatrin peptide

A unique synthetic natriuretic and vasorelaxing peptide

Chi Ming Wei, Cheolho Kim, Virginia M. Miller, John C. Burnett

Research output: Contribution to journalArticleResearchpeer-review

57 Citations (Scopus)

Abstract

This study reports the cardiovascular and renal actions of a novel and newly synthesized 27-amino acid peptide termed vasonatrin peptide (VNP). VNP is a chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP). This synthetic peptide possesses the 22-amino acid structure of CNP, which is a cardiovascular selective peptide of endothelial origin and is structurally related to ANP. VNP also possesses the five-amino acid COOH terminus of ANP. The current study demonstrates both in vitro and in vivo that VNP possesses the venodilating actions of CNP, the natriuretic actions of ANP, and unique arterial vasodilating actions not associated with either ANP or CNP.

Original languageEnglish
Pages (from-to)2048-2052
Number of pages5
JournalJournal of Clinical Investigation
Volume92
Issue number4
DOIs
StatePublished - 1 Jan 1993

Fingerprint

Natriuretic Peptides
C-Type Natriuretic Peptide
Atrial Natriuretic Factor
Amino Acids
Peptides
peptide A
eel ventricular natriuretic peptide
Kidney

Keywords

  • Cardiorenal function
  • Cgmp
  • Endothelium
  • Natriuretic peptide
  • Vasorelaxation

Cite this

Wei, Chi Ming ; Kim, Cheolho ; Miller, Virginia M. ; Burnett, John C. / Vasonatrin peptide : A unique synthetic natriuretic and vasorelaxing peptide. In: Journal of Clinical Investigation. 1993 ; Vol. 92, No. 4. pp. 2048-2052.
@article{d4e3dd021064459398f6a6eee9b9b46c,
title = "Vasonatrin peptide: A unique synthetic natriuretic and vasorelaxing peptide",
abstract = "This study reports the cardiovascular and renal actions of a novel and newly synthesized 27-amino acid peptide termed vasonatrin peptide (VNP). VNP is a chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP). This synthetic peptide possesses the 22-amino acid structure of CNP, which is a cardiovascular selective peptide of endothelial origin and is structurally related to ANP. VNP also possesses the five-amino acid COOH terminus of ANP. The current study demonstrates both in vitro and in vivo that VNP possesses the venodilating actions of CNP, the natriuretic actions of ANP, and unique arterial vasodilating actions not associated with either ANP or CNP.",
keywords = "Cardiorenal function, Cgmp, Endothelium, Natriuretic peptide, Vasorelaxation",
author = "Wei, {Chi Ming} and Cheolho Kim and Miller, {Virginia M.} and Burnett, {John C.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1172/JCI116800",
language = "English",
volume = "92",
pages = "2048--2052",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "4",

}

Vasonatrin peptide : A unique synthetic natriuretic and vasorelaxing peptide. / Wei, Chi Ming; Kim, Cheolho; Miller, Virginia M.; Burnett, John C.

In: Journal of Clinical Investigation, Vol. 92, No. 4, 01.01.1993, p. 2048-2052.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Vasonatrin peptide

T2 - A unique synthetic natriuretic and vasorelaxing peptide

AU - Wei, Chi Ming

AU - Kim, Cheolho

AU - Miller, Virginia M.

AU - Burnett, John C.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - This study reports the cardiovascular and renal actions of a novel and newly synthesized 27-amino acid peptide termed vasonatrin peptide (VNP). VNP is a chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP). This synthetic peptide possesses the 22-amino acid structure of CNP, which is a cardiovascular selective peptide of endothelial origin and is structurally related to ANP. VNP also possesses the five-amino acid COOH terminus of ANP. The current study demonstrates both in vitro and in vivo that VNP possesses the venodilating actions of CNP, the natriuretic actions of ANP, and unique arterial vasodilating actions not associated with either ANP or CNP.

AB - This study reports the cardiovascular and renal actions of a novel and newly synthesized 27-amino acid peptide termed vasonatrin peptide (VNP). VNP is a chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP). This synthetic peptide possesses the 22-amino acid structure of CNP, which is a cardiovascular selective peptide of endothelial origin and is structurally related to ANP. VNP also possesses the five-amino acid COOH terminus of ANP. The current study demonstrates both in vitro and in vivo that VNP possesses the venodilating actions of CNP, the natriuretic actions of ANP, and unique arterial vasodilating actions not associated with either ANP or CNP.

KW - Cardiorenal function

KW - Cgmp

KW - Endothelium

KW - Natriuretic peptide

KW - Vasorelaxation

UR - http://www.scopus.com/inward/record.url?scp=0027448795&partnerID=8YFLogxK

U2 - 10.1172/JCI116800

DO - 10.1172/JCI116800

M3 - Article

VL - 92

SP - 2048

EP - 2052

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 4

ER -